Difference between revisions of "Seminoma"

Jump to navigation Jump to search
696 bytes added ,  19:24, 12 April 2022
no edit summary
 
(5 intermediate revisions by the same user not shown)
Line 8: Line 8:
| LMDDx      = [[embryonal carcinoma]], [[GCNIS]], [[mixed germ cell tumour]], [[granulomatous orchitis]], [[testicular scar]], [[atrophic testis]]  
| LMDDx      = [[embryonal carcinoma]], [[GCNIS]], [[mixed germ cell tumour]], [[granulomatous orchitis]], [[testicular scar]], [[atrophic testis]]  
| Stains    =
| Stains    =
| IHC        = OCT3 +ve, CD117 +ve, CD30 -ve
| IHC        = OCT4 +ve, [[CD117]] +ve, CD30 -ve
| EM        =
| EM        =
| Molecular  =
| Molecular  =
Line 22: Line 22:
| Symptoms  =
| Symptoms  =
| Prevalence =
| Prevalence =
| Bloodwork  = LDH elevated, beta-hCG elevated (not common)
| Bloodwork  = LDH elevated, beta-hCG normal or slightly elevated
| Rads      =
| Rads      =
| Endoscopy  =
| Endoscopy  =
Line 32: Line 32:
'''Seminoma''' is a common [[testis|testicular]] [[germ cell tumour]].
'''Seminoma''' is a common [[testis|testicular]] [[germ cell tumour]].


It should ''not'' be confused with the unrelated tumour called ''[[spermatocytic seminoma]]''.
It should ''not'' be confused with ''[[spermatocytic tumour]]'' (previously known as ''spermatocytic seminoma'').


==General==
==General==
Line 41: Line 41:
*Elevated serum LDH.
*Elevated serum LDH.
*Normal serum alpha fetoprotein.  
*Normal serum alpha fetoprotein.  
*Usually normal beta-hCG.
*Usually normal beta-hCG ''or'' slightly elevated.<ref name=pmid9311009>{{cite journal |authors=Hori K, Uematsu K, Yasoshima H, Yamada A, Sakurai K, Ohya M |title=Testicular seminoma with human chorionic gonadotropin production |journal=Pathol Int |volume=47 |issue=9 |pages=592–9 |date=September 1997 |pmid=9311009 |doi=10.1111/j.1440-1827.1997.tb04547.x |url=}}</ref>


Note:
Note:
Line 125: Line 125:
A general panel:<ref name=pmid24832161>{{cite journal |author=Ulbright TM, Tickoo SK, Berney DM, Srigley JR |title=Best practices recommendations in the application of immunohistochemistry in testicular tumors: report from the international society of urological pathology consensus conference |journal=Am. J. Surg. Pathol. |volume=38 |issue=8 |pages=e50–9 |year=2014 |month=August |pmid=24832161 |doi=10.1097/PAS.0000000000000233 |url=}}</ref>
A general panel:<ref name=pmid24832161>{{cite journal |author=Ulbright TM, Tickoo SK, Berney DM, Srigley JR |title=Best practices recommendations in the application of immunohistochemistry in testicular tumors: report from the international society of urological pathology consensus conference |journal=Am. J. Surg. Pathol. |volume=38 |issue=8 |pages=e50–9 |year=2014 |month=August |pmid=24832161 |doi=10.1097/PAS.0000000000000233 |url=}}</ref>
*OCT4 +ve.
*OCT4 +ve.
**Choriocarcinoma, yolk sac tumour and spermatocytic seminoma all -ve.
**Choriocarcinoma, yolk sac tumour and [[spermatocytic tumour]] all -ve.
*CD117 +ve.
*CD117 +ve.
**-ve in embryonal carcinoma.
**-ve in embryonal carcinoma.
Line 148: Line 148:


==Sign out==
==Sign out==
<pre>
Right Testicle, Radical Orchitectomy:
    - SEMINOMA (pure).
    -- Margins clear.
    -- Germ cell neoplasia in situ (intratubular germ cell neoplasia) present.
    -- Please see synoptic report.
    - Background testis consists of Sertoli cells only, NEGATIVE for spermatogenesis.
</pre>
<pre>
<pre>
Testis, Left, Radical Orchiectomy:
Testis, Left, Radical Orchiectomy:
- SEMINOMA (pure).
    - SEMINOMA (pure).
-- Margins clear.
    -- Margins clear.
-- Please see synoptic report.
    -- Please see synoptic report.
</pre>
</pre>


Line 158: Line 167:
<pre>
<pre>
RETROPERITONEAL SOFT TISSUE, RIGHT, CORE BIOPSY:
RETROPERITONEAL SOFT TISSUE, RIGHT, CORE BIOPSY:
- SEMINOMA.
    - SEMINOMA.
</pre>
</pre>


48,466

edits

Navigation menu